Randomized trialMedical2026
Cannabis Retail Responses to Pregnant Individuals in New York: Business Practices and Policy Compliance.
Wysota C.; Young-Wolff K.; Khanna M.; Patippe C.; Does M.; Metz T.; Abroms L.; Sherman S.; Rogers E. · Substance use & addiction journal · 2026
Research summary
**Background & Methods**
This cross-sectional mystery-shopper study evaluated cannabis retailer responses to pregnant individuals across all licensed adult-use cannabis retailers in New York State (n=422) between February-April 2026. Callers posed as pregnant individuals using randomized scripts (nausea vs. non-nausea presentations), and retailer websites were reviewed for pregnancy-related warnings. Outcomes assessed included characterization of cannabis safety during pregnancy, mode-specific recommendations, and referrals to healthcare professionals.
**Key Findings**
• Retailer messaging was highly variable: 3% stated cannabis use during pregnancy was safe, 51% advised against use, 12% expressed uncertainty, and 35% deferred medical guidance without recommendation either way.
• Approximately 30% of retailers differentiated safety by route of administration, with edibles most frequently endorsed as safer (27%) compared to smoking (22% identified as most harmful); 54% spontaneously recommended consulting a healthcare professional, while 39% did so only after prompting.
• Significant regional variation existed in retailer advice (P<.001), with New York City retailers more likely to advise against cannabis use during pregnancy compared to suburban and upstate retailers, though no differences were observed between the nausea and non-nausea script conditions.
**Dosage & Administration**
Not reported.
**Safety & Adverse Effects**
Not reported.
**Evidence Quality**
This study demonstrates moderate evidence quality with important limitations. The mystery-shopper methodology provides real-world retailer behavior data but cannot capture all interactions or account for caller-specific factors that may influence responses. The lack of script effect (nausea vs. non-nausea) was unexpected and unexplained. The cross-sectional design prevents causal inference, and retailer compliance measurement relied on verbal reports rather than validated documentation. Geographic variation findings suggest unmeasured confounding by region-specific policies or retailer demographics. Overall, findings indicate general regulatory compliance but highlight substantial standardization gaps, suggesting need for formal retailer training protocols and clearer regulatory guidance to ensure consistent, evidence-based communication regarding cannabis use in pregnancy.
Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.
Journal
Substance use & addiction journal
Study type
Randomized trial
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed
More recent cannabis research
This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.